# Bristol-Myers Squibb Company (NYSE: BMY), New Brunswick, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/bristol-myers-squibb-company/485fabe1-4ba4-46ef-b997-6467e4c074a1

> Inspection records and compliance data for Bristol-Myers Squibb Company in New Brunswick, New Jersey. 6 FDA inspections on record, last inspected December 12, 2025. Publicly traded as NYSE: BMY.

---

## Details

- Name: Bristol-Myers Squibb Company
- FEI Number: 2211101
- Address Line 1: 1 Squibb Dr
- City: New Brunswick
- State: New Jersey
- Zip Code: 08901
- Country Name: United States
- Address: 1 Squibb Dr, New Brunswick, New Jersey 08901, United States
- Country: United States

## Stock

- Stock ticker: BMY
- Exchange: NYSE
- Share price: $63.24
- Market cap: $129.3B
- Price as of: November 6, 2026

## Related Documents

- FDA Inspection 1299176 - Bristol-Myers Squibb Company - 2025-12-12 — source: FDA, date: December 12, 2025
- FDA Inspection 1228554 - Bristol-Myers Squibb Company - 2023-12-01 — source: FDA, date: December 1, 2023
- FDA Inspection 1034312 - Bristol-Myers Squibb Company - 2017-10-13 — source: FDA, date: October 13, 2017
- FDA Inspection 857661 - Bristol-Myers Squibb Company - 2013-11-22 — classification: No Action Indicated (NAI), source: FDA, date: November 22, 2013
- FDA Inspection 652918 - Bristol-Myers Squibb Company - 2010-03-22 — classification: No Action Indicated (NAI), source: FDA, date: March 22, 2010
- [FDA Inspection 547474 - Bristol-Myers Squibb Company - 2008-11-20](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/fa38d6fd-880e-4dc3-bfd8-cef8d0aa3237) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 20, 2008

## Related Companies

- [Melinta Therapeutics, LLC.](https://www.keypedia.com/companies/melinta-therapeutics-llc/67072c93-5e5e-4a2e-86e3-bc81b3f90fe6)
- [Glenmark Pharmaceuticals Inc., USA](https://www.keypedia.com/companies/glenmark-pharmaceuticals-inc-usa/a6863099-84a2-4d3f-b3e7-ed7c8ef8abf9)
- [Rebgro Corporation](https://www.keypedia.com/companies/rebgro-corporation/d079f70f-98ec-4ec4-888f-fe48aa712b67)
- [Allcare Medical](https://www.keypedia.com/companies/allcare-medical/4c4275e4-929d-4652-819f-86ef3d1f3e86)
- [Scott E. Eder, M.D.](https://www.keypedia.com/companies/scott-e-eder-md/56dadf9f-fbfe-4ce9-a8b0-aa33de80e96f)
- [Lucasti Christopher, D.O.](https://www.keypedia.com/companies/lucasti-christopher-do/af4f0a02-9154-42fd-b0f1-7c35dfb6813d)
- [Genmab US, Inc.](https://www.keypedia.com/companies/genmab-us-inc/c0dfae89-b227-4fa6-a6ed-240e587cc288)
- [Pfizer Inc](https://www.keypedia.com/companies/pfizer-inc/2789218e-b17d-494f-8132-63b8925721fd)
- [NS Pharma, Inc.](https://www.keypedia.com/companies/ns-pharma-inc/de5785b0-ea59-4296-9313-9038dbc12b70)
- [Forest Research Institute, Inc.](https://www.keypedia.com/companies/forest-research-institute-inc/a083d1d8-92a5-4df6-878d-d6813ff153b0)